血清前素水平与前不服用药物精神分裂症患者的认知功能之间的关系:一个横截面研究
Guoshuai Luo1, Fengfeng Bai1, Xuehui Qu1
1Laboratory of Biological Psychiatry, Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, 13 Liulin Road, Tianjin, 300222, China.
Journal of neural transmission (Vienna, Austria : 1996)
|January 26, 2024
概括
血清前素水平与精神病症状或认知缺陷没有关联在药物先验精神分裂症患者. 尽管有显著的认知障碍,但在这个患者群体中,益生菌与症状严重程度或认知功能无关.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 内分泌学 在内分泌学.
背景情况:
- 精神分裂症的特点是认知缺陷.
- 精神分裂症中超性乳腺血的作用尚未完全理解.
- 研究像益生素这样的生物标志物对于理解精神分裂症至关重要.
研究的目的:
- 为了检查血清前素水平和精神症状之间的关系.
- 评估血清前素水平与认知功能之间的关联.
- 为了研究这些协会在药物先验精神分裂症患者.
主要方法:
- 招募了91名以前没有服用过药物的精神分裂症患者和67名健康对照.
- 使用测量和治疗研究来改善精神分裂症的认知 (MATRICS) 评估认知功能共识认知电池 (MCCB).
- 测量了血清前素水平,并分析了与临床和认知数据的相关性.
主要成果:
- 与对照人群相比,以前没有服用过药物的精神分裂症患者在所有七个MCCB领域都表现出严重的认知缺陷.
- 血清益乳素水平和临床症状严重程度之间没有发现显著的相关性.
- 在这些患者中,血清益乳素水平和认知功能之间没有显著的相关性.
结论:
- 血清前素水平似乎与药物先验精神分裂症的认知缺陷或精神症状无关.
- 认知障碍是精神分裂症早期的一个重要特征.
- 需要进一步的研究来确定精神分裂症的可靠生物标志物.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
48
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48
Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
Psychosis and Antipsychotic Drugs: Overview
259
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
259
Psychological and Sociocultural Causes of Schizophrenia
89
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
89
Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
648
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
648


